Selective immunolesion of cholinergic neurons leads to long-term changes in 5-HT2A receptor levels in hippocampus and frontal cortex

Neuroscience Letters

Volumn 428, Issue 1, 2007, Pages 47-51

  Severino, Maurizio ^a   Pedersen, Anja F ^a   Trajkovska, Viktorija ^a   Christensen, Ellen ^a   Lohals, Rasmus ^b   Veng, Lone M ^b   Knudsen, Gitte M ^a   Aznar, Susana ^a  

^a Center for Integrated Molecular Brain Imaging   (Denmark)

^b H LUNDBECK A S   (Denmark)

Author keywords

Alzheimer; Cholinergic deafferentation; Depression; Rat; Serotonin receptor

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOTOXIN; SAPORIN; SEROTONIN; SEROTONIN 2A RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DEAFFERENTATION; DOWN REGULATION; FOREBRAIN; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOTOXICITY; MALE; NERVE CELL LESION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEROTONINERGIC SYSTEM;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN INJURIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FRONTAL LOBE; HIPPOCAMPUS; MALE; NEURONS; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RIBOSOME INACTIVATING PROTEINS, TYPE 1; TIME FACTORS;

EID: 35448937166     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.09.026     Document Type: Article

References (51)

1. Adolfsson R., Gottfries C.G., Roos B.E., and Winblad B. Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br. J. Psychiatry 135 (1979) 216-223
2. Arai H., Kosaka K., and Iizuka R. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia. J. Neurochem. 43 (1984) 388-393
3. Assal F., and Cummings J.L. Neuropsychiatric symptoms in the dementias. Curr. Opin. Neurol. 15 (2002) 445-450
4. Aznar S., Kostova V., Christiansen S.H., and Knudsen G.M. alpha7 nicotinic receptor subunit is present on serotonin neurons projecting to hippocampus and septum. Synapse 55 (2005) 196-200
5. Cahir M., Ardis T., Reynolds G.P., and Cooper S.J. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 190 (2007) 497-506
6. Cohen H. Anxiolytic effect and memory improvement in rats by antisense oligodeoxynucleotide to 5-hydroxytryptamine-2A precursor protein. Depress Anxiety 22 (2005) 84-93
7. Cross A.J., Crow T.J., Ferrier I.N., Johnson J.A., Bloom S.R., and Corsellis J.A. Serotonin receptor changes in dementia of the Alzheimer type. J. Neurochem. 43 (1984) 1574-1581
8. Cyr M., Charbonneau C., Morissette M., Rochford J., Barden N., and Di Paolo T. Central 5-hydroxytryptamine-2A receptor expression in transgenic mice bearing a glucocorticoid receptor antisense. Neuroendocrinology 73 (2001) 37-45
9. Dajas-Bailador F., and Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol. Sci. 25 (2004) 317-324
10. Deutch A.Y., Holliday J., Roth R.H., Chun L.L., and Hawrot E. Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 8697-8701
11. Dewar D., Graham D.I., and McCulloch J. 5 HT2 receptors in dementia of Alzheimer type: a quantitative autoradiographic study of frontal cortex and hippocampus. J. Neural Transm. Park Dis. Dement Sect. 2 (1990) 129-137
12. Dhaenen H. Imaging the serotonergic system in depression. Eur. Arch. Psychiatry Clin. Neurosci. 251 2 (2001) II76-II80
13. Fabian-Fine R., Skehel P., Errington M.L., Davies H.A., Sher E., Stewart M.G., and Fine A. Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J. Neurosci. 21 (2001) 7993-8003
14. File S.E., Kenny P.J., and Cheeta S. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety. Pharmacol. Biochem. Behav. 66 (2000) 65-72
15. Garcia-Alloza M., Gil-Bea F.J., Diez-Ariza M., Chen C.P., Francis P.T., Lasheras B., and Ramirez M.J. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease. Neuropsychologia 43 (2005) 442-449
16. Hasselbalch S.G., Madsen K., Svarer C., Pinborg L.H., Holm S., Paulson O.B., Waldemar G., and Knudsen G.M. Reduced 5-HT(2A) receptor binding in patients with mild cognitive impairment. Neurobiol. Aging (2007)
17. Helm K.A., Han J.S., and Gallagher M. Effects of cholinergic lesions produced by infusions of 192 IgG-saporin on glucocorticoid receptor mRNA expression in hippocampus and medial prefrontal cortex of the rat. Neuroscience 115 (2002) 765-774
18. Kenny P.J., File S.E., and Neal M.J. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J. Neurochem. 75 (2000) 2409-2414
19. Kepe V., Barrio J.R., Huang S.C., Ercoli L., Siddarth P., Shoghi-Jadid K., Cole G.M., Satyamurthy N., Cummings J.L., Small G.W., and Phelps M.E. Serotonin 1A receptors in the living brain of Alzheimer's disease patients. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 702-707
20. Kornum B.R., Weikop P., Moller A., Ronn L.C., Knudsen G.M., and Aznar S. Serotonin depletion results in a decrease of the neuronal activation caused by rivastigmine in the rat hippocampus. Brain Res. 1073-1074 (2006) 262-268
21. Lai M.K., Tsang S.W., Alder J.T., Keene J., Hope T., Esiri M.M., Francis P.T., and Chen C.P. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease. Psychopharmacology (Berl) 179 (2005) 673-677
22. Leanza G., Muir J., Nilsson O.G., Wiley R.G., Dunnett S.B., and Bjorklund A. Selective immunolesioning of the basal forebrain cholinergic system disrupts short-term memory in rats. Eur. J. Neurosci. 8 (1996) 1535-1544
23. Leanza G., Nilsson O.G., Wiley R.G., and Bjorklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur. J. Neurosci. 7 (1995) 329-343
24. Lehmann O., Bertrand F., Jeltsch H., Morer M., Lazarus C., Will B., and Cassel J.C. 5,7-DHT-induced hippocampal 5-HT depletion attenuates behavioural deficits produced by 192 IgG-saporin lesions of septal cholinergic neurons in the rat. Eur. J. Neurosci. 15 (2002) 1991-2006
25. Lehmann O., Jeltsch H., Lazarus C., Tritschler L., Bertrand F., and Cassel J.C. Combined 192 IgG-saporin and 5,7-dihydroxytryptamine lesions in the male rat brain: a neurochemical and behavioral study. Pharmacol. Biochem. Behav. 72 (2002) 899-912
26. Li X., Rainnie D.G., McCarley R.W., and Greene R.W. Presynaptic nicotinic receptors facilitate monoaminergic transmission. J. Neurosci. 18 (1998) 1904-1912
27. Lorke D.E., Lu G., Cho E., and Yew D.T. Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients. BMC Neurosci. 7 (2006) 36
28. Mann D.M., and Yates P.O. Serotonin nerve cells in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 46 (1983) 96
29. Meneses A. Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism?. Cell Mol. Neurobiol. 22 (2002) 675-688
30. Messa C., Colombo C., Moresco R.M., Gobbo C., Galli L., Lucignani G., Gilardi M.C., Rizzo G., Smeraldi E., Zanardi R., Artigas F., and Fazio F. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl) 167 (2003) 72-78
31. Mihailescu S., Palomero-Rivero M., Meade-Huerta P., Maza-Flores A., and Drucker-Colin R. Effects of nicotine and mecamylamine on rat dorsal raphe neurons. Eur. J. Pharmacol. 360 (1998) 31-36
32. Minger S.L., Esiri M.M., McDonald B., Keene J., Carter J., Hope T., and Francis P.T. Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology 55 (2000) 1460-1467
33. Morilak D.A., Garlow S.J., and Ciaranello R.D. Immunocytochemical localization and description of neurons expressing serotonin2 receptors in the rat brain. Neuroscience 54 (1993) 701-717
34. Mufson E.J., Ma S.Y., Dills J., Cochran E.J., Leurgans S., Wuu J., Bennett D.A., Jaffar S., Gilmor M.L., Levey A.I., and Kordower J.H. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 443 2 (2002) 136-153
35. Mugnaini M., Tessari M., Tarter G., Merlo Pich E., Chiamulera C., and Bunnemann B. Upregulation of 3H methylycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. Eur. J. Neurosci. 16 (2002) 1633-1646
36. Nordberg A. Neuroreceptor changes in Alzheimer disease. Cerebrovasc. Brain Metab. Rev. 4 (1992) 303-328
37. Ohno M., and Watanabe S. Blockade of 5-HT1A receptors compensates loss of hippocampal cholinergic neurotransmission involved in working memory of rats. Brain Res. 736 (1996) 180-188
38. Ribeiro E.B., Bettiker R.L., Bogdanov M., and Wurtman R.J. Effects of systemic nicotine on serotonin release in rat brain. Brain Res. 621 (1993) 311-318
39. Rossner S., Schliebs R., Hartig W., and Bigl V. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull. 38 (1995) 371-381
40. Rossor M.N., Iversen L.L., Reynolds G.P., Mountjoy C.Q., and Roth M. Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br. Med. J. (Clin. Res. Ed.) 288 (1984) 961-964
41. Sarter M., and Bruno J.P. Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities. Neurobiol. Aging 25 (2004) 1127-1139
42. Seth P., Cheeta S., Tucci S., and File S.E. Nicotinic-serotonergic interactions in brain and behaviour. Pharmacol. Biochem. Behav. 71 (2002) 795-805
43. Tribollet E., Bertrand D., Marguerat A., and Raggenbass M. Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain. Neuroscience 124 (2004) 405-420
44. Tucci S.A., Genn R.F., and File S.E. Methyllycaconitine (MLA) blocks the nicotine evoked anxiogenic effect and 5-HT release in the dorsal hippocampus: possible role of alpha7 receptors. Neuropharmacology 44 (2003) 367-373
45. Versijpt J., Van Laere K.J., Dumont F., Decoo D., Vandecapelle M., Santens P., Goethals I., Audenaert K., Slegers G., Dierckx R.A., and Korf J. Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings. Neurobiol. Aging 24 (2003) 553-561
46. Vertes R.P. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J. Comp. Neurol. 313 (1991) 643-668
47. Vertes R.P., Fortin W.J., and Crane A.M. Projections of the median raphe nucleus in the rat. J. Comp. Neurol. 407 (1999) 555-582
48. Waite J.J., Chen A.D., Wardlow M.L., Wiley R.G., Lappi D.A., and Thal L.J. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience 65 (1995) 463-476
49. Weisstaub N.V., Zhou M., Lira A., Lambe E., Gonzalez-Maeso J., Hornung J.P., Sibille E., Underwood M., Itohara S., Dauer W.T., Ansorge M.S., Morelli E., Mann J.J., Toth M., Aghajanian G., Sealfon S.C., Hen R., and Gingrich J.A. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313 (2006) 536-540
50. Wiley R.G., Oeltmann T.N., and Lappi D.A. Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor. Brain Res. 562 (1991) 149-153
51. Yamamoto T., and Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann. Neurol. 17 (1985) 573-577